| Q58699124 | A Low Frequency of IL-17-Producing CD8 T-Cells Is Associated With Persistent Immune Activation in People Living With HIV Despite HAART-Induced Viral Suppression |
| Q58580465 | Abnormal T Cell Frequencies, Including Cytomegalovirus-Associated Expansions, Distinguish Seroconverted Subjects at Risk for Type 1 Diabetes |
| Q37564579 | Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development |
| Q90084055 | Activation of mucosal-associated invariant T cells in the lungs of sarcoidosis patients |
| Q37697841 | Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus |
| Q93186441 | Airway CD8+CD161++TCRvα7.2+ T Cell Depletion During Untreated HIV Infection Targets CD103 Expressing Cells |
| Q92846258 | Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic Hepatitis |
| Q35018923 | Altered CD161 bright CD8+ mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics |
| Q60920287 | Altered composition and phenotype of mucosal-associated invariant T cells in early untreated rheumatoid arthritis |
| Q40263239 | Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients. |
| Q27680179 | Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells |
| Q35752258 | Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection |
| Q90290433 | Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients |
| Q35494621 | Attrition of TCR Vα7.2+ CD161++ MAIT cells in HIV-tuberculosis co-infection is associated with elevated levels of PD-1 expression |
| Q40059465 | CD161 Expression on Mucosa-Associated Invariant T Cells is Reduced in HIV-Infected Subjects Undergoing Antiretroviral Therapy Who Do Not Recover CD4+ T Cells |
| Q34450282 | CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression |
| Q39098086 | CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner |
| Q92857870 | CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy |
| Q37739063 | Challenge of Humans with Wild-type Salmonella enterica Serovar Typhi Elicits Changes in the Activation and Homing Characteristics of Mucosal-Associated Invariant T Cells |
| Q91432435 | Characterization and Purification of Mouse Mucosal-Associated Invariant T (MAIT) Cells |
| Q91432474 | Characterization of Human Mucosal-associated Invariant T (MAIT) Cells |
| Q33630962 | Check MAIT. |
| Q36536034 | Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients |
| Q34075150 | Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses |
| Q37689104 | Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer |
| Q27694492 | Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward |
| Q52598286 | Contribution of APCs to mucosal-associated invariant T cell activation in infectious disease and cancer. |
| Q38747458 | Controlled Human Malaria Infection Leads to Long-Lasting Changes in Innate and Innate-like Lymphocyte Populations. |
| Q40163118 | Decrease of CD69 levels on TCR Vα7.2+CD4+ innate-like lymphocytes is associated with impaired cytotoxic functions in chronic hepatitis B virus-infected patients. |
| Q50066272 | Development of Asthma in Inner-City Children: Possible Roles of MAIT Cells and Variation in the Home Environment |
| Q59304306 | Development of mucosal-associated invariant T cells |
| Q40053061 | Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure. |
| Q37016414 | Distinct activation thresholds of human conventional and innate-like memory T cells |
| Q92642986 | Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection |
| Q36448225 | Dynamic Perturbations of the T-Cell Receptor Repertoire in Chronic HIV Infection and following Antiretroviral Therapy |
| Q26800118 | Early innate responses to pathogens: pattern recognition by unconventional human T-cells |
| Q37227889 | Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling |
| Q64912367 | Factors Influencing Functional Heterogeneity in Human Mucosa-Associated Invariant T Cells. |
| Q36077824 | Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy |
| Q35815577 | Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites. |
| Q89495082 | Functional MAIT Cells Are Associated With Reduced Simian-Human Immunodeficiency Virus Infection |
| Q38852261 | Functional role of mucosal-associated invariant T cells in HIV infection. |
| Q36132003 | Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression |
| Q34662270 | HIV infection: epidemiology, pathogenesis, treatment, and prevention |
| Q36112685 | HIV-Infected Children Have Lower Frequencies of CD8+ Mucosal-Associated Invariant T (MAIT) Cells that Correlate with Innate, Th17 and Th22 Cell Subsets |
| Q38902093 | High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells |
| Q50045500 | Human blood MAIT cell subsets defined using MR1 tetramers. |
| Q37247617 | Human mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18-dependent activation |
| Q52608541 | Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection. |
| Q40866100 | IL-15 dependent induction of IL-18 secretion as a feedback mechanism controlling human MAIT-cell effector functions |
| Q89948602 | IL-17 production by tissue-resident MAIT cells is locally induced in children with pneumonia |
| Q37104112 | Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy |
| Q55078288 | Impact of Aging on the Frequency, Phenotype, and Function of CD161-Expressing T Cells. |
| Q34399419 | Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. |
| Q52654737 | Innate-like CD8+ T-cells and NK cells: converging functions and phenotypes. |
| Q28085321 | Innate-like lymphocytes in intestinal infections |
| Q46314074 | Interactions between bile salts, gut microbiota, and hepatic innate immunity. |
| Q40093638 | Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation |
| Q64116658 | Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies |
| Q55408012 | Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells. |
| Q93047695 | Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis |
| Q35082485 | Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection |
| Q58588189 | Low mucosal-associated invariant T-cell number in peripheral blood of patients with immune thrombocytopenia and their response to prednisolone |
| Q40593130 | MAIT be different-persisting dysfunction after DAA-mediated clearance of chronic hepatitis C virus infection |
| Q48223629 | MAIT cell clonal expansion and TCR repertoire shaping in human volunteers challenged with Salmonella Paratyphi A. |
| Q47551345 | MAIT cells and Viruses |
| Q38244066 | MAIT cells and pathogen defense |
| Q35847725 | MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis |
| Q27469032 | MAIT cells are activated during human viral infections |
| Q47550378 | MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection |
| Q37104082 | MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection |
| Q41687115 | MAIT cells are depleted early but retain functional cytokine expression in HIV infection |
| Q34890728 | MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. |
| Q36338406 | MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications |
| Q58568564 | MAIT cells contribute to protection against lethal influenza infection in vivo |
| Q58722526 | MAIT cells protect against pulmonary Legionella longbeachae infection |
| Q28073095 | MAIT cells: new guardians of the liver |
| Q26852490 | MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases |
| Q48137360 | Maximal exercise increases mucosal associated invariant T cell frequency and number in healthy young men. |
| Q36153599 | Molecular Analyses Define Vα7.2-Jα33+ MAIT Cell Depletion in HIV Infection: A Case-Control Study |
| Q36811942 | Mucosa-Associated Invariant T Cells Are Systemically Depleted in Simian Immunodeficiency Virus-Infected Rhesus Macaques |
| Q45071749 | Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease |
| Q92058744 | Mucosal Immunity in HIV/SIV Infection: T Cells, B Cells and Beyond |
| Q36014529 | Mucosal-Associated Invariant T (MAIT) Cells Are Impaired in Th17 Associated Primary and Secondary Immunodeficiencies |
| Q40340158 | Mucosal-Associated Invariant T Cell Deficiency in Chronic Obstructive Pulmonary Disease |
| Q49204780 | Mucosal-Associated Invariant T Cell Interactions with Commensal and Pathogenic Bacteria: Potential Role in Antimicrobial Immunity in the Child |
| Q54963446 | Mucosal-Associated Invariant T Cells Are Depleted and Exhibit Altered Chemokine Receptor Expression and Elevated Granulocyte Macrophage-Colony Stimulating Factor Production During End-Stage Renal Disease. |
| Q55301095 | Mucosal-Associated Invariant T Cells in Autoimmune Diseases. |
| Q54268263 | Mucosal-Associated Invariant T Cells in Chronic Inflammatory Liver Disease. |
| Q26781518 | Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out |
| Q47241753 | Mucosal-Associated Invariant T Cells in Regenerative Medicine |
| Q96640817 | Mucosal-associated invariant T (MAIT) cells provide B-cell help in vaccinated and subsequently SIV-infected Rhesus Macaques |
| Q35408930 | Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients |
| Q35829274 | Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation. |
| Q90514963 | Mucosal-associated invariant T cells and Vδ2+ γδ T cells in community acquired pneumonia: association of abundance in sputum with clinical severity and outcome |
| Q91904779 | Mucosal-associated invariant T cells and disease |
| Q38891491 | Mucosal-associated invariant T cells are numerically and functionally deficient in patients with mycobacterial infection and reflect disease activity |
| Q26750384 | Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseases |
| Q40100401 | Mucosal-associated invariant T-cell frequency and function in blood and liver of HCV mono- and HCV/HIV co-infected patients with advanced fibrosis. |
| Q34305082 | Mucosal-associated invariant T-cells: new players in anti-bacterial immunity |
| Q33887115 | Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines. |
| Q27007035 | Nonclassical T cells and their antigens in tuberculosis |
| Q40703746 | Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy |
| Q54256962 | OMIP-046: Characterization of invariant T cell subset activation in humans. |
| Q48232467 | Ontogeny of human mucosal-associated invariant T cells and related T cell subsets |
| Q50131423 | Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection |
| Q38892515 | Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients |
| Q35016866 | Persistent changes in circulating and intestinal γδ T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease. |
| Q34851102 | Persistent immune activation in chronic HIV infection: do any interventions work? |
| Q59352469 | Preexisting Simian Immunodeficiency Virus Infection Increases Susceptibility to Tuberculosis in Mauritian Cynomolgus Macaques |
| Q54214704 | Proteomic definition of human mucosal-associated invariant T cells determines their unique molecular effector phenotype. |
| Q27685209 | Recognition of vitamin B metabolites by mucosal-associated invariant T cells |
| Q40970092 | Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease |
| Q34309058 | Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis. |
| Q26797333 | Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials |
| Q47589231 | Role of MAIT cells in the immunopathogenesis of inflammatory diseases: New players in old game. |
| Q40044893 | Shared and Distinct Phenotypes and Functions of Human CD161++ Vα7.2+ T Cell Subsets. |
| Q42250131 | Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. |
| Q93091820 | Successful direct-acting antiviral therapy in HIV/HCV co-infected patients fails to restore circulating mucosal-associated invariant T cells |
| Q90017407 | Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection |
| Q89972703 | Swimming Against the Current: MAIT Cell Function Is Preserved in the Peritoneum of Advanced Liver Disease Patients |
| Q26865650 | T cell recognition of non-peptidic antigens in infectious diseases |
| Q37631857 | TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells |
| Q93159444 | The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool |
| Q37345995 | The Impact of Sex Work Interruption on Blood-Derived T Cells in Sex Workers from Nairobi, Kenya |
| Q58697988 | The Role of CD1d and MR1 Restricted T Cells in the Liver |
| Q92579050 | The biology and functional importance of MAIT cells |
| Q38280290 | The effect of HIV infection on the host response to bacterial sepsis |
| Q33808773 | The loss of CCR6+ and CD161+ CD4+ T-cell homeostasis contributes to disease progression in SIV-infected rhesus macaques |
| Q96135217 | The role of interleukin-17 in asthma: a protective response? |
| Q38955495 | The role of mucosal-associated invariant T cells in infectious diseases |
| Q58102795 | Tissue-resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL-17 |
| Q64100923 | Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector molecules |
| Q90989324 | Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation |
| Q26991896 | Universal immunity to influenza must outwit immune evasion |
| Q90044629 | Virus-Mediated Suppression of the Antigen Presentation Molecule MR1 |
| Q37732225 | Will loss of your MAITs weaken your HAART [corrected]? |